newsfilter
← Latest News
GlobeNewswire·

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026

  • Organogenesis Holdings Inc. will report third quarter fiscal year 2026 financial results after market close on November 5, 2026.
  • Management will host a conference call at 5:00 p.m. Eastern Time on November 5, 2026, to discuss quarterly results & provide a corporate update.
  • The call will include a question & answer session accessible via live webcast or teleconference.
  • The webcast will be archived on investors.organogenesis.com for approximately one year.
  • Organogenesis is a regenerative medicine company focused on advanced wound care, surgical, & sports medicine markets.